RP
Rapid Micro Biosystems, Inc.
RPID · NASDAQ
$1.09 -3.54% (-$0.04)
1M -35.88%
Market Cap $49.4M
P/E Ratio -
Div. Yield -
ROE 177.04%
Bulios Fair Price
$1.52
39.4% upside
Current Price
$1.09
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RPID is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
82 /100
Cheap P/S 1.40x
P/B 2.78x
P/E N/A
Growth
78 /100
Growing Rev. growth 25.15%
Book val. growth 41.30%
EPS growth N/A
Profitability
1 /100
Weak Gross margin 10.03%
Net margin 145.56%
Op. margin 141.45%
Quality
8 /100
Poor ROIC 119.67%
ROE 177.04%
ROA 87.60%
Debt
42 /100
Moderate Debt/Equity 1.32x
Current ratio 2.55x
Int. coverage -19.36x
Stability
71 /100
Stable Beta 1.44x
Rev. volatility 5.88%
EPS volatility 6.16%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RPID
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert G. Spignesi Jr.
Employees
171
Headquarters
Lexington
Upcoming events
06 NOV
Earnings
Upcoming earnings report